These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
653 related articles for article (PubMed ID: 30394846)
1. Prevalence and Mechanisms of Carbapenem Resistance Among Benmahmod AB; Said HS; Ibrahim RH Microb Drug Resist; 2019 May; 25(4):480-488. PubMed ID: 30394846 [TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt. Al-Agamy MH; Khalaf NG; Tawfick MM; Shibl AM; El Kholy A Int J Infect Dis; 2014 May; 22():49-54. PubMed ID: 24607428 [TBL] [Abstract][Full Text] [Related]
3. Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii in a Tertiary Care Hospital in Egypt: Clonal Spread of blaOXA-23. El Bannah AMS; Nawar NN; Hassan RMM; Salem STB Microb Drug Resist; 2018 Apr; 24(3):269-277. PubMed ID: 28783427 [TBL] [Abstract][Full Text] [Related]
4. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients. Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602 [TBL] [Abstract][Full Text] [Related]
6. Emergence of carbapenem-resistant Acinetobacter baumannii in hospitals in Pakistan. Hasan B; Perveen K; Olsen B; Zahra R J Med Microbiol; 2014 Jan; 63(Pt 1):50-55. PubMed ID: 24085817 [TBL] [Abstract][Full Text] [Related]
7. Evolution of carbapenem resistance in Acinetobacter baumannii: an 18-year longitudinal study from a medical center in northern Taiwan. Ku WW; Kung CH; Lee CH; Tseng CP; Wu PF; Kuo SC; Chen TL; Lee YT; Wang FD; Fung CP J Microbiol Immunol Infect; 2015 Feb; 48(1):57-64. PubMed ID: 24064289 [TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of oxacillinases among carbapenem-resistant Acinetobacter baumannii nosocomial isolates in a Saudi hospital. Elabd FM; Al-Ayed MS; Asaad AM; Alsareii SA; Qureshi MA; Musa HA J Infect Public Health; 2015; 8(3):242-7. PubMed ID: 25466594 [TBL] [Abstract][Full Text] [Related]
9. Dissemination of bla Leungtongkam U; Thummeepak R; Wongprachan S; Thongsuk P; Kitti T; Ketwong K; Runcharoen C; Chantratita N; Sitthisak S Microb Drug Resist; 2018; 24(1):55-62. PubMed ID: 28594634 [TBL] [Abstract][Full Text] [Related]
10. ISAba1 Regulated OXA-23 Carbapenem Resistance in Acinetobacter baumannii Strains in Durban, South Africa. Agoba EE; Govinden U; Peer AKC; Osei Sekyere J; Essack SY Microb Drug Resist; 2018 Nov; 24(9):1289-1295. PubMed ID: 29653481 [TBL] [Abstract][Full Text] [Related]
12. Carbapenem-resistant Acinetobacter baumannii: Current status of the problem in four Bulgarian university hospitals (2014-2016). Strateva T; Sirakov I; Stoeva T; Stratev A; Dimov S; Savov E; Mitov I J Glob Antimicrob Resist; 2019 Mar; 16():266-273. PubMed ID: 30412782 [TBL] [Abstract][Full Text] [Related]
13. Co-production of AmpC and extended spectrum beta-lactamases in cephalosporin-resistant Acinetobacter baumannii in Egypt. Said HS; Benmahmod AB; Ibrahim RH World J Microbiol Biotechnol; 2018 Dec; 34(12):189. PubMed ID: 30511216 [TBL] [Abstract][Full Text] [Related]
14. Phenotypic and genotypic characterization of carbapenem-resistant Abouelfetouh A; Torky AS; Aboulmagd E Antimicrob Resist Infect Control; 2019; 8():185. PubMed ID: 31832185 [TBL] [Abstract][Full Text] [Related]
15. Deciphering Multidrug-Resistant Acinetobacter baumannii from a Pediatric Cancer Hospital in Egypt. Jalal D; Elzayat MG; Diab AA; El-Shqanqery HE; Samir O; Bakry U; Hassan R; Elanany M; Shalaby L; Sayed AA mSphere; 2021 Dec; 6(6):e0072521. PubMed ID: 34787450 [TBL] [Abstract][Full Text] [Related]
16. OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq. Ganjo AR; Maghdid DM; Mansoor IY; Kok DJ; Severin JA; Verbrugh HA; Kreft D; Fatah MH; Alnakshabandi AA; Dlnya A; Hammerum AM; Ng K; Goessens W Microb Drug Resist; 2016 Dec; 22(8):627-637. PubMed ID: 27003287 [TBL] [Abstract][Full Text] [Related]
17. Conversion of OXA-66 into OXA-82 in clinical Acinetobacter baumannii isolates and association with altered carbapenem susceptibility. Zander E; Chmielarczyk A; Heczko P; Seifert H; Higgins PG J Antimicrob Chemother; 2013 Feb; 68(2):308-11. PubMed ID: 23014718 [TBL] [Abstract][Full Text] [Related]
18. Molecular Characterization of Carbapenem-Resistant Acinetobacter baumannii in the Intensive Care Unit of Uruguay's University Hospital Identifies the First rmtC Gene in the Species. Bado I; Papa-Ezdra R; Delgado-Blas JF; Gaudio M; Gutiérrez C; Cordeiro NF; García-Fulgueiras V; Araújo Pirez L; Seija V; Medina JC; Rieppi G; Gonzalez-Zorn B; Vignoli R Microb Drug Resist; 2018 Sep; 24(7):1012-1019. PubMed ID: 29920143 [TBL] [Abstract][Full Text] [Related]
19. Emergence of Carbapenem-Hydrolyzing Oxacillinases in Acinetobacter baumannii in Children from Croatia. Lukić-Grlić A; Kos M; Žižek M; Luxner J; Grisold A; Zarfel G; Bedenić B Chemotherapy; 2019; 64(4):167-172. PubMed ID: 31707391 [TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiology and antimicrobial resistance phenotypes of Acinetobacter baumannii isolated from patients in three hospitals in southern Vietnam. Tuan Anh N; Nga TVT; Tuan HM; Tuan NS; Y DM; Vinh Chau NV; Baker S; Duong HHT J Med Microbiol; 2017 Jan; 66(1):46-53. PubMed ID: 28198682 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]